In England, the rise in diabetes was estimated to have offset mortality improvements by 7.4% overall, but by 14% in the more deprived areas of England and by only 2% in wealthier areas (Bajekal et al., Such results indicate that the advancements in equal access to high quality treatments are being threatened by the unequal distribution in risk factors such as diabetes. The number of deaths caused by CVD varies considerably across OECD countries.